Analyst Price Targets — TS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 9:30 am | — | Morgan Stanley | $65.00 | $56.31 | TheFly | Tenaris upgraded to Equal Weight from Underweight at Morgan Stanley |
| May 18, 2026 11:21 am | — | Piper Sandler | $60.00 | $61.77 | TheFly | Tenaris price target raised to $60 from $56 at Piper Sandler |
| May 14, 2026 10:46 am | — | Morgan Stanley | $53.00 | $63.60 | TheFly | Tenaris price target raised to $53 from $50 at Morgan Stanley |
| May 8, 2026 10:38 am | David Anderson | Barclays | $82.00 | $58.96 | TheFly | Tenaris price target raised to $82 from $78 at Barclays |
| May 7, 2026 11:31 am | — | Barclays | $78.00 | $62.43 | TheFly | Tenaris price target raised to $78 from $72 at Barclays |
| April 20, 2026 9:56 am | David Anderson | Barclays | $72.00 | $58.61 | TheFly | Tenaris price target raised to $72 from $56 at Barclays |
| April 15, 2026 11:25 am | — | Morgan Stanley | $50.00 | $58.92 | TheFly | Tenaris price target raised to $50 from $40 at Morgan Stanley |
| April 15, 2026 11:13 am | Derek Podhaizer | Piper Sandler | $56.00 | $58.92 | TheFly | Tenaris price target raised to $56 from $42 at Piper Sandler |
| February 23, 2026 5:18 pm | — | Goldman Sachs | $49.70 | $53.44 | TheFly | Tenaris price target raised to $49.70 from $44.60 at Goldman Sachs |
| February 23, 2026 12:08 pm | — | Stifel Nicolaus | $57.00 | $52.26 | TheFly | Tenaris price target raised to $57 from $45 at Stifel |
Latest News for TS
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Tenaris (TS) have what it takes?
Toronto, Ontario – TheNewswire - July 15, 2026 – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC), today announced the initiation of its Phase IIb clinical trial site at Hannover Medical School, Hanover (“MHH”), Germany, for SCI-110, its proprietary cannabinoid-based treatment candidate for…
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.1%, we present two other…
PARAMARIBO, Suriname, June 30, 2026 (GLOBE NEWSWIRE) -- Tenaris announced today that operations have started at its new service center in Suriname, built to support the GranMorgu project, the country's first major offshore development, operated by TotalEnergies, with APA Corporation and Staatsolie Maatschappij Suriname N.V. as partners. Located in Paramaribo, the center will provide integrated services for offshore…
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Tenaris (TS) have what it takes?
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for TS.
Senate Trading
No Senate trades found for TS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.